GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
2,537
Funds Holding Change
+172
Funds Holding Growth
+7%
Value
$482B
Holding in Top 10
558
Top 10 Change
+80
Top 10 Growth
+17%
Value Growth
+9%
New
273
Increased
1,035
Reduced
1,079
Closed
70
Capital Inflow
$24.9B
Capital Outflow
$17.7B
Net Capital Flow
+$7.25B
Capital Flow Change
+$8.12B
Calls
$7.44B
Puts
$8.36B
Net Calls
-$914M
Put/Call Ratio
1.12